B cells as drivers towards clinical SLE manifestation
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterised by the production of autoantibodies, particularly against nuclear antigens that form immune complexes and lead to widespread organ damage. These autoantibodies are produced by plasma cells (PCs), which are terminally differentiated B cells specialised in antibody secretion.
Autoantibody producing PCs are oftentimes resistant to conventional immunosuppressive therapies, highlighting the need to identify novel therapeutic targets.
PCs can survive for extended periods within specialised microenvironments called survival niches and provide essential survival signals. While long-lived PCs are known to reside in bone marrow niches, under inflammatory conditions other organs such as the spleen and kidney can support PC survival.
In a first part of the project, we aim to investigate the composition and characteristics of PC survival niches within the spleen of lupus-prone mice.

- Projects
- 1st Generation
- 2nd Generation
- A: Defining Autoimmune Pre-Disease
- A10: Define the impact of shift work on autoimmunity and autoimmune diseases
- A11: T cell memory differentiation in early autoimmune disease. Department of Rheumatology and Clinical Immunology, University of Lübeck
- A12: Genetic And Molecular Similarity Of Autoimmune Disease
- A13: B cells as drivers towards clinical SLE manifestation
- A14: Exploring Novel Genetic Variants and the Pathogenicity of Autoantibodies in Pemphigus Vulgaris
- A15: Anne-Sophie Pagel - tba
- A16: Yasaman Mirzaee - tba
- B: Targeting of Autoimmune Pre-Disease
- Associated projects
- MD projects
- Concluded projects
- A: Defining Autoimmune Pre-Disease
Doctoral researcher

Participating Researchers


Mentor
Hanna Grasshoff